The mission of the MRC Versus Arthritis Centre for Musculoskeletal Ageing Research (CMAR) is to increase understanding of the biology of age-related musculoskeletal deterioration, to include identification of the factors influencing an individual’s trajectory towards frailty and the processes underpinning the transition to musculoskeletal
disease. We are building an internationally recognised and globally networked research platform, capable of generating novel and clinically testable approaches to reduce musculoskeletal
ageing and disease.
Through strategic collaborative working with other centres of excellence in the UK and overseas
, the MRC Versus Arthritis Centre for Musculoskeletal Ageing Research
is leveraging the expertise, resource and facilities required to achieve a step change in mechanistic understanding and the testing and implementation of interventions, ensuring the impact on musculoskeletal
health at scale.
Working with health service providers and policymakers will ensure that we can continue to operate in a range of delivery settings and accelerate adoption of our findings.